Aarti Pharmalabs Limited has announced the grant of 57,600 stock options to eligible employees under its APL Performance Stock Option Plan 2023. This initiative, approved by the Nomination and Remuneration Committee on May 25, 2026, aims to incentivize and reward the workforce. The options are set at an exercise price of Rs. 5 per share, reflecting the company’s commitment to employee wealth creation and long-term organizational growth.
Stock Option Grant Details
During a meeting held on May 25, 2026, the Nomination and Remuneration Committee of Aarti Pharmalabs Limited officially approved the grant of 57,600 stock options. These options are being issued to specific eligible employees across both the company and its subsidiary, reinforcing the organization’s focus on talent retention and employee participation in company growth.
Terms of the Plan
The grant is executed under the APL Performance Stock Option Plan 2023. A key detail of this issuance is the exercise price, which has been fixed at Rs. 5 per option. This structure is part of the company’s broader strategic framework to align employee interests with shareholder value, ensuring that key team members are invested in the future success of Aarti Pharmalabs.
Source: BSE
